Public Comments

Publish Date
Public Comments
C4IP Written Submission for Inv. No. 332-596
Council for Innovation Promotion
Public Comments
Public Comments on European Commission Draft SEP Regulation
Council for Innovation Promotion
Public Comments
C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program
Council for Innovation Promotion
Public Comments
C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Council for Innovation Promotion
Public Comments
C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025)
Council for Innovation Promotion
Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023

Resources:

Resources:

Public Comments on European Commission Draft SEP Regulation,

04/19/2023

Resources:

Resources:

C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program,

04/14/2023

Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023

Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023

Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023

Scroll to Top